McDermott JH - Search Results

1

Development and Validation of a Rapid Point-of-Care CYP2C19 Genotyping Platform.

Burke KA, O'Sullivan J, Godfrey N, Sharma V, Hilton S, Wright SJ, Greaves NS, Newman WG, McDermott JH. Burke KA, et al. Among authors: mcdermott jh. J Mol Diagn. 2024 Dec 24:S1525-1578(24)00312-X. doi: 10.1016/j.jmoldx.2024.12.001. Online ahead of print. J Mol Diagn. 2024. PMID: 39725012 Free article.

2

Patient and public involvement in hearing research: opportunities, impact and reflections with case studies from the Manchester Centre for Audiology and Deafness.

Dawes P, Arru P, Corry R, McDermott JH, Garlick J, Guest H, Howlett E, Jackson I, James R, Keane A, Murray C, Newman W, Visram A, Munro KJ. Dawes P, et al. Among authors: mcdermott jh. Int J Audiol. 2024 Feb;63(2):146-154. doi: 10.1080/14992027.2022.2155881. Epub 2022 Dec 26. Int J Audiol. 2024. PMID: 36573267 Free article.

3

Letters to the Editor.

McDermott JH, Newman WG. McDermott JH, et al. J Paediatr Child Health. 2023 Mar;59(3):600. doi: 10.1111/jpc.16376. Epub 2023 Feb 13. J Paediatr Child Health. 2023. PMID: 36779317 No abstract available.

4

MT-RNR1 Genotype Should Not Affect Childhood Vaccination-Unintended Consequences of Guidelines.

McDermott JH, Wolf J, Newman WG. McDermott JH, et al. JAMA Pediatr. 2023 Nov 1;177(11):1119-1120. doi: 10.1001/jamapediatrics.2023.3263. JAMA Pediatr. 2023. PMID: 37695579

5

Public preferences for pharmacogenetic testing in the NHS: Embedding a discrete choice experiment within service design to better meet user needs.

McDermott JH, Sharma V, Newman WG, Wilson P, Payne K, Wright S. McDermott JH, et al. Br J Clin Pharmacol. 2024 Jul;90(7):1699-1710. doi: 10.1111/bcp.16058. Epub 2024 Apr 14. Br J Clin Pharmacol. 2024. PMID: 38616172

6

Rapid point of care testing: the next frontier in pharmacogenomics.

Leach M, Newman WG, McDermott JH. Leach M, et al. Among authors: mcdermott jh. Pharmacogenomics. 2024;25(7):289-291. doi: 10.1080/14622416.2024.2366691. Epub 2024 Jul 23. Pharmacogenomics. 2024. PMID: 39041736 No abstract available.

7

Pharmacogenetics Clinical Decision Support Systems for Primary Care in England: Co-Design Study.

Sharma V, McDermott J, Keen J, Foster S, Whelan P, Newman W. Sharma V, et al. J Med Internet Res. 2024 Jul 23;26:e49230. doi: 10.2196/49230. J Med Internet Res. 2024. PMID: 39042886 Free PMC article.

8

Understanding general practitioner and pharmacist preferences for pharmacogenetic testing in primary care: a discrete choice experiment.

McDermott JH, Sharma V, Beaman GM, Keen J, Newman WG, Wilson P, Payne K, Wright S. McDermott JH, et al. Pharmacogenomics J. 2024 Aug 9;24(5):25. doi: 10.1038/s41397-024-00344-z. Pharmacogenomics J. 2024. PMID: 39122683 Free PMC article.

9

CYP2C19 genetic testing for Mavacamten and ischaemic stroke treatment: What does the result mean for cardiovascular prescribers in the UK and Europe?

Magavern EF, McDermott JH, Caulfield MJ, Newman WG. Magavern EF, et al. Among authors: mcdermott jh. Eur Heart J Cardiovasc Pharmacother. 2024 Oct 4;10(6):481-483. doi: 10.1093/ehjcvp/pvae040. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 39175266 No abstract available.

10

Pre-Emptive Pharmacogenetic Testing in the Acute Hospital Setting: A Cross-Sectional Study.

McDermott JH, Burke K, Fullerton N, O'Sullivan J, Alex A, Ingham A, Sharma V, Godfrey N, Odudu A, Syed T, Stevens A, Beynon R, Greaves N, Akam D, Mirza S, Wilson P, Wright S, Payne K, Newman WG. McDermott JH, et al. QJM. 2024 Oct 17:hcae200. doi: 10.1093/qjmed/hcae200. Online ahead of print. QJM. 2024. PMID: 39418209

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

159 results

Search Page

Filters